New Biomarker Development Alliance Aims to Address 'Urgent' Need for Standards | GenomeWeb

NEW YORK (GenomeWeb News) – A non-profit organization called the National Biomarker Development Alliance has launched to develop standards and guidelines for supporting biomarker development and use, the NBDA said today.

The NBDA was created to "address the complex and urgent challenge of creating the standards to support end-to-end evidence-based biomarker development," and will engage partners from industry, academia, government, and patient groups, NBDA said.

The alliance was established and launched today by the Research Collaboratory at Arizona State University

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.